Direct sales giant Mary Kay has announced the appointment of Dr. Lucy Gildea as Chief Scientific Officer, who will head up the Global Research and Development function for the company.

As part of her role, Dr. Gildea will develop innovative products and increase the number of patents for the company. Likewise she will be responsible for developing and executing Mary Kay’s Global Product Strategy and Innovative Pipeline.

Thomas Cho, Chief Supply Chain Officer for Mary Kay, said, “Dr. Gildea’s proven track record and success to embed high efficacy science in the personal care product industry will enhance Mary Kay’s ability to provide innovative products and technology that consumers are unable to find elsewhere.
“From her time working internationally, Dr. Gildea’s global perspective brings great value as Mary Kay continues to expand and works to understand the needs of customers in all markets.”

Based in the company’s global headquarters in Addison, Texas, Dr. Gildea joins with extensive experience having previously spent 15 years at Procter & Gamble.